Bioworld Financial Watch articles from October 2007

Bioworld Financial Watch archives from October 2007

Quest for new sleep drugs bearing fruit, inspiring deals.(Target 'Hangover' Effect, The Elderly)
October 1, 2007... Insomnia made headlines last month by way of a company takeover, the purchase of drug rights in Europe, and mixed but intriguing Phase II results with a much-needed, potential new player in the $3 billion U.S. market. It's a market ripe...

U.S. public offering performance by underwriter: January 1--August 31, 2007.
October 1, 2007... U.S. Public Offering Performance By Underwriter: January 1--August 31, 2007 * ALL OFFERINGS, ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * UNDERWRITER GROSS PROCEEDS (M) (NUMBER OF OFFERINGS AS...

BioWorld stock report for public Biotechnology Companies.
October 1, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 9/21 9/28 WK YTD (000) Aastrom Biosci ASTM 1.12...

Despite difficulty of hepatitis C landscape, firms keep focus.(HCV Space Grows Ever More Crowded)
October 8, 2007... Nothing was more in the news of biotech during the past week than hepatitis C virus. Thanks to setbacks and blowups with drug candidates, HCV has taken plenty of headline space in general this year, and the space seems due to grow ever hotter,...

Public financing of Biotechnology: September 2007.
October 8, 2007... Public Financing Of Biotechnology: September 2007 I. COMMENCED TRADING IN SEPTEMBER Company Date Date Shares/ Price Shares Lead, Other (Symbol) # Filed Comm. Units Out (M) Underwriters ...

Other financings of public Biotechnology companies: September 2007.
October 8, 2007... Other Financings Of Public Biotechnology Companies: September 2007 TOTAL: $422.05M Company (Symbol) # Type Of Financing Number Of Amount Shares, Raised ...

Venture capital and other investments in Private Biotechnology Companies: September 2007.
October 8, 2007... Venture Capital And Other Investments In Private Biotechnology Companies: September 2007 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $499.05M Company Location Date Amt. (M) AdvanDx Inc. ...

Milestones/Equity Investment from corporate partners: Sept. 2007.
October 8, 2007... SEPT. TOTAL: $50M Company # * Partner (Country) Amt. Triggering (Symbol) (M) Event BioDelivery Meda AB (Sweden) $30 Milestone Sciences ...

Money raised by biotech in 2007: January-September.
October 8, 2007... Money Raised By Biotech In 2007: January-September Type of Jan. Feb. March April May financing Public 573.50 655.36 1,74.05 559.13 1,257.45 offerings Private 518.65 ...

BioWorld stock Indicator 2007, Nasdaq Biotech Index 2007.
October 8, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public Biotechnology Companies.
October 8, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 9/28 10/5 WK YTD (000) Aastrom Biosci ASTM 1.16...

CTI plans Zevalin's revival; satraplatin wait soon over.(BIO InvestorForum)
October 15, 2007... SAN FRANCISCO -- Remember Zevalin? The oncetrumpeted radioactive immune therapy for non-Hodgkin's lymphoma from IDEC Pharmaceuticals Inc. (now Biogen Idec Inc.) won approval in February 2002. Hopes ran high, with sales projections in the $500...

Clinical trials update: September 2007.
October 15, 2007... Clinical Trials Update: September 2007 Company * (Country; Product Symbol) AUTOIMMUNE Alba Therapeutics Corp. * AT-1001 CollaGenex Incyclinide Pharmaceuticals Inc. (CGPI) CombinatoRx Inc....

Non-U.S. clinical trials and regulatory actions: September 2007.
October 15, 2007... Non-U.S. Clinical Trials And Regulatory Actions: September 2007 Company * Product Description (Country; Symbol) CANCER Celgene Revlimid Lenalidomide; oral International drug...

FDA submissions, approvals and other actions: September 2007.
October 15, 2007... FDA Submissions, Approvals And Other Actions: September 2007 Company * Product Description (Country; Symbol) CANCER Genzyme Corp. Campath Alemtuzumab (GENZ) (FDA-approved) ...

BioWorld stock report for public biotechnology companies.
October 15, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 10/5 10/12 WK YTD (000) Aastrom Biosci ASTM 1.29 1.23 ...

Savient travels gout route; Phase III results due shortly.(Orphan Drug For Treatment Failures)
October 22, 2007... As a therapeutic indication, rheumatoid arthritis gets more love from investors, but another painful joint disorder has come to the fore as well, and Savient Pharmaceuticals Inc. is the company they talk about when they talk about gout. An...

Biotechnology Company deals with other Biotechnology Companies: Aug. 17 - Oct. 17, 2007.
October 22, 2007... Company* Company* Type/Product Area (Country; (Country; Symbol) Symbol) 454 Life Perlegen Agreement to conduct Sciences* Sciences Inc.* large-scale genetic ...

Biotechnology Company deals with miscellaneous companies: Aug. 17-Oct. 17, 2007.
October 22, 2007... Biotechnology Company Deals With Miscellaneous Companies: Aug. 17 - Oct. 17, 2007 Company* Company Type/Product Terms/Details (Date) (Country; Area Symbol) Kylin Fort Dodge Collaboration...

Manufacturing, marketing and distribution agreements between Biotech Companies: Aug. 17 - Oct. 17, 2007.
October 22, 2007... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Aug. 17 - Oct. 17, 2007 Company* Company* Type/Product Area (Country; (Country; Symbol) Symbol) ...

Biotech-Biotech collaborations: modified agreements: Aug. 17 - Oct. 17, 2007.
October 22, 2007... Biotech-Biotech Collaborations: Modified Agreements: Aug. 17 - Oct. 17, 2007 Company* Company Type/Product Area Terms/Details (Country; (Country; (Date) Symbol) Symbol) I....

BioWorld stock report for public Biotechnology Companies.
October 22, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 10/12 10/19 WK YTD (000) Aastrom Biosci ASTM 1.23 ...

While RA bids line runway, poll finds unhappy patients.(Anti-TNFs, Rituxan, Orencia ... ?)
October 29, 2007... The phrase "rheumatoid arthritis" almost right away calls to mind Genentech Inc.'s Rituxan (rituximab, which targets the CD20 antigen, for RA and non-Hodgkin's lymphoma). Partnered for marketing with Biogen Idec Inc. and cleared by the FDA...

Collaborations between Biotechnology Companies and Government/Nonprofit Institutions: Aug. 31 - Oct. 18, 2007.
October 29, 2007... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Aug. 31 -Oct. 18, 2007 Company* (Country; University/ Type Of Symbol) Nonprofit@ Agreement ActiveSight* ...

BioWorld stock report for Public Biotechnology Companies.
October 29, 2007... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 10/19 10/26 WK YTD (000) Aastrom Biosci ASTM 1.18 1.05...